Insider · CIK 0001303311

McWilliams David

Reports to the SEC for 2 companies · THE WOODLANDS, TX

sec.gov

Transactions

Companies

Filings

CIK

0001303311

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-12-24	GLSIGreenwich LifeSciences, Inc. · Stock OptionsA Award	Director	AAward	+62K sh	—	—	123,968
2022-06-22	GLSIGreenwich LifeSciences, Inc. · Stock OptionsA Award	Director	AAward	+62K sh	—	—	61,984
2021-12-14	GLSIGreenwich LifeSciences, Inc.P Purchase	Director	PPurchase	+200 sh	$27.56	+$5,512.18	620,301
2020-11-20	GLSIGreenwich LifeSciences, Inc.P Purchase	Director	PPurchase	+1,500 sh	$5.40	+$8,100	620,101
2020-09-29	GLSIGreenwich LifeSciences, Inc.P Purchase	Director	PPurchase	+2,608 sh	$5.75	+$15K	446,979
2020-09-29	GLSIGreenwich LifeSciences, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+153K sh	—	—	599,583
2020-09-29	GLSIGreenwich LifeSciences, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,663 sh	—	—	607,246
2020-09-29	GLSIGreenwich LifeSciences, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,746 sh	—	—	610,992
2020-09-29	GLSIGreenwich LifeSciences, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,609 sh	—	—	618,601
2020-09-29	GLSIGreenwich LifeSciences, Inc. · Series A Preferred StockM Exercise/Conversion	Director	MExercise/Conversion	−153K sh	—	—	0
2020-09-29	GLSIGreenwich LifeSciences, Inc. · Series B Preferred StockM Exercise/Conversion	Director	MExercise/Conversion	−7,663 sh	—	—	0
2020-09-29	GLSIGreenwich LifeSciences, Inc. · Series C Preferred StockM Exercise/Conversion	Director	MExercise/Conversion	−3,746 sh	—	—	0
2020-09-29	GLSIGreenwich LifeSciences, Inc. · Series D Preferred StockM Exercise/Conversion	Director	MExercise/Conversion	−6,555 sh	—	—	0
2020-09-29	GLSIGreenwich LifeSciences, Inc. · Series D Preferred StockJ Other	Director	JOther	+1,054 sh	—	—	1,054
2020-09-29	GLSIGreenwich LifeSciences, Inc. · Series D Preferred StockM Exercise/Conversion	Director	MExercise/Conversion	−1,054 sh	—	—	0
2009-08-26	Acer Therapeutics Inc.Common Stock Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	246,668
2009-08-23	Acer Therapeutics Inc.Common Stock Option (right to buy)J Other	Director	JOther	−37K sh	—	—	238,668
2009-02-06	Acer Therapeutics Inc.Common Stock Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	275,668
2007-06-18	Acer Therapeutics Inc.Common Stock Option (right to buy)A Award	Director	AAward	+41K sh	—	—	203,000
2006-06-15	Acer Therapeutics Inc.Common Stock Option (right to buy)A Award	Director	AAward	+120K sh	—	—	162,000
2005-12-14	Acer Therapeutics Inc.P Purchase	Director	PPurchase	+2,000 sh	$0.63	+$1,260	66,256
2005-07-18	Acer Therapeutics Inc.P Purchase	Director	PPurchase	+23.3K sh	—	—	64,256
2005-07-18	Acer Therapeutics Inc.Series A WarrantP Purchase	Director	PPurchase	+1 sh	—	—	7
2005-07-18	Acer Therapeutics Inc.Series B WarrantP Purchase	Director	PPurchase	+1 sh	—	—	8
2005-07-18	Acer Therapeutics Inc.Series C WarrantP Purchase	Director	PPurchase	+1 sh	—	—	9
2005-06-30	Acer Therapeutics Inc.J Other	Director	JOther	+36.9K sh	—	—	40,922
2005-06-30	Acer Therapeutics Inc.15% Subordinated Convertible NoteJ Other	Director	JOther	−2 sh	—	—	0
2005-06-30	Acer Therapeutics Inc.Warrant (right to buy)J Other	Director	JOther	−2 sh	—	—	0
2005-06-30	Acer Therapeutics Inc.Series A WarrantJ Other	Director	JOther	+2 sh	—	—	2
2005-06-30	Acer Therapeutics Inc.Series B WarrantJ Other	Director	JOther	+2 sh	—	—	4
2005-06-30	Acer Therapeutics Inc.Series C WarrantJ Other	Director	JOther	+2 sh	—	—	6
2005-01-21	Acer Therapeutics Inc.Common Stock Option (right to buy)A Award	Director	AAward	+1 sh	—	—	420,000

Recent filings

Accepted (ET)
Dec 274
McWilliams David0001493152-24-052261
SEC(opens sec.gov)
Jun 244
McWilliams David0001493152-22-017654
SEC(opens sec.gov)
Dec 164
McWilliams David0001493152-21-031651
SEC(opens sec.gov)
Nov 244
McWilliams David0001493152-20-022375
SEC(opens sec.gov)
Sep 304
McWilliams David0001213900-20-029372
SEC(opens sec.gov)
Sep 294
McWilliams David0001213900-20-029060
SEC(opens sec.gov)
Aug 274
McWilliams David0001310880-09-000005
SEC(opens sec.gov)
Feb 94
McWilliams David0001313516-09-000005
SEC(opens sec.gov)
Jun 194
McWilliams David0001360851-07-000002
SEC(opens sec.gov)
Jun 194
Opexa Therapeutics, Inc.0001293831-06-000006
SEC(opens sec.gov)

Companies

Address

2635 N. CRESCENT RIDGE DRIVE

THE WOODLANDS, TX, 77381